# Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer

> **NCT00274859** · PHASE2 · UNKNOWN · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group** · enrollment: 45 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00274859
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2008-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274859, "Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00274859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*